MarketLens

Pricing Plans Sign Up Log in

Stock Analysis Pro

What's Behind Clene's Recent Stock Volatility and Insider Sales

1 months ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

What Do Recent Visa Insider Sales Signal for Investors

3 months ago

What's Behind the Recent Insider Sales at Regency Centers

3 months ago

What's Driving Jefferies' Recent Stock Volatility

3 months ago

What's Behind the Recent Congressional Stock Sales in Regional Banks

3 months ago

What a $227,000 GeneDx Insider Sale Means as Revenue Climbs 17%

GeneDx CFO sold 3,729 Class A shares (~$227K) on June 16, reducing his direct stake by 8.54%, even as revenue climbed 17%.

WGS

Stock News•2 weeks ago

Nan Fung Group Sells $4.3 Million in Oculis Shares As Lead Drug Stumbles

Nan Fung Group sold $4.3M in Oculis shares after the lead drug stumbled, signaling insider concern over the clinical-stage biotech's late-stage topical therapies for diabetic and neuro-ophthalmic eye ...

OCS

Stock News•1 months ago

Insiders Are Buying These 3 Stocks

Insider transaction activity is being monitored by investors as a potential indicator of long-term corporate health. While specific stock names were not disclosed, tracking these trades may provide in...

CHTR

Stock News•1 months ago

Clene Stock Jumps After FDA Opens Door To Accelerated Approval For ALS Drug

Clene Inc. (CLNN) shares rose 6.68% on Monday after the company announced plans to file for accelerated approval of its ALS treatment. This move follows a constructive meeting with the FDA, potentiall...

CLNN